Cargando…

The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy

Cardiovascular diseases (CVDs) and metabolic disorders are major components of noncommunicable diseases, causing an enormous health and economic burden worldwide. There are common risk factors and developmental mechanisms among them, indicating the far-reaching significance in exploring the correspo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Yunfei, Tan, Mingyue, Han, Lianhua, Zhang, Lei, Zhang, Yue, Zhang, Jun, Pan, Wanqian, Bai, Jiaxiang, Jiang, Tingbo, Li, Hongxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213817/ https://www.ncbi.nlm.nih.gov/pubmed/37250161 http://dx.doi.org/10.1016/j.apsb.2023.01.015

Ejemplares similares

Comprehensive overview of Nrf2-related epigenetic regulations involved in ischemia-reperfusion injury
por: Zhang, Jun, et al.
Publicado: (2022)

Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis
por: Tan, Mingyue, et al.
Publicado: (2023)

Impaired liver regeneration in aged mice can be rescued by silencing Hippo core kinases MST1 and MST2
por: Loforese, Giulio, et al.
Publicado: (2016)

Structural basis for Mob1-dependent activation of the core Mst–Lats kinase cascade in Hippo signaling
por: Ni, Lisheng, et al.
Publicado: (2015)

Mst1 and Mst2 kinases: regulations and diseases
por: Qin, Funiu, et al.
Publicado: (2013)

Regulation of Neuronal Cell Death by c-Abl-Hippo/MST2 Signaling Pathway
por: Liu, Weizhe, et al.
Publicado: (2012)

The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair
por: Fallahi, Emma, et al.
Publicado: (2016)

Structural basis of the heterodimerization of the MST and RASSF SARAH domains in the Hippo signalling pathway
por: Hwang, Eunha, et al.
Publicado: (2014)

MST kinases in development and disease
por: Thompson, Barry J., et al.
Publicado: (2015)

The kinases Mst1 and Mst2 positively regulate phagocyte ROS induction and bactericidal activity
por: Geng, Jing, et al.
Publicado: (2015)

MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
por: Meng, Zhipeng, et al.
Publicado: (2015)

Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control
por: Kulaberoglu, Yavuz, et al.
Publicado: (2017)

Effect of taurine on the proliferation, apoptosis and MST1/Hippo signaling in prostate cancer cells
por: Song, Xu, et al.
Publicado: (2022)

MST kinases in innate immune signaling
por: Shi, Zhubing, et al.
Publicado: (2017)

MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression
por: Sun, Yan, et al.
Publicado: (2023)

NETs Lead to Sympathetic Hyperactivity After Traumatic Brain Injury Through the LL37-Hippo/MST1 Pathway
por: Zhu, Kaixin, et al.
Publicado: (2021)

Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner
por: García-Gutiérrez, Lucía, et al.
Publicado: (2022)

Pharmacotherapy Options in Rheumatoid Arthritis
por: Kumar, Pradeep, et al.
Publicado: (2013)

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
por: Grześk, Grzegorz, et al.
Publicado: (2023)

Gaseous signalling molecule SO(2) via Hippo-MST pathway to improve myocardial fibrosis of diabetic rats
por: Liu, Maojun, et al.
Publicado: (2017)

Hippo/Mst signaling coordinates cellular quiescence with terminal maturation in iNKT cell development and fate decisions
por: Raynor, Jana L., et al.
Publicado: (2020)

The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes
por: Mou, Fan, et al.
Publicado: (2012)

Rassf Proteins as Modulators of Mst1 Kinase Activity
por: Bitra, Aruna, et al.
Publicado: (2017)

The cGAS–STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy
por: Oduro, Patrick Kwabena, et al.
Publicado: (2022)

DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2
por: Kwan, Julian, et al.
Publicado: (2016)

The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary
por: Lyu, Zhichao, et al.
Publicado: (2016)

Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer
por: Lim, Shen Kiat, et al.
Publicado: (2020)

MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker
por: Jin, Xiang, et al.
Publicado: (2021)

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitus
por: Wang, Junjie, et al.
Publicado: (2023)

New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)

MST4 Kinase Inhibitor Hesperadin Attenuates Autophagy and Behavioral Disorder via the MST4/AKT Pathway in Intracerebral Hemorrhage Mice
por: Wu, Xiaodong, et al.
Publicado: (2020)

Cardiovascular Pharmacotherapy Focus
por: Avanzas, Pablo
Publicado: (2019)

Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Effect of Inactivation of Mst1 and Mst2 in the Mouse Adrenal Cortex
por: Abou Nader, Nour, et al.
Publicado: (2022)

Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
por: Garakani, Amir, et al.
Publicado: (2021)

Survey of MST Studies
por: Barbalat, O
Publicado: (1974)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Cattaneo, Mattia, et al.
Publicado: (2019)

Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation
por: Li, Peng, et al.
Publicado: (2013)

Mst1 and Mst2 Are Essential Regulators of Trophoblast Differentiation and Placenta Morphogenesis
por: Du, Xingrong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c3fucb2bgb5gg1d82eniqun4rh